82
Participants
Start Date
April 4, 2023
Primary Completion Date
December 30, 2024
Study Completion Date
December 30, 2024
remote patient monitoring
"Cureety is a digital telemonitoring platform, specifically designed to monitor signs and symptoms of disease progression and AEs in cancer patients. The digital tool is adaptable to specific treatments and disease settings. The platform collects various data including treatment delays, dose reductions, quality of life and safety data. In terms of safety, once configured for the treatment and disease setting, the patient responds to an electronic PRO (ePRO) questionnaire based on the NCI-CTCAE version (v)5.0.10 Depending on the responses, an algorithm classifies patients as either correct, compromised, state to be monitored, or critical state. Depending on the classification, patients are notified of the actions to be taken."
RECRUITING
Centre Hospitalier de Bligny, Briis-sous-Forges
Collaborators (4)
Exystat
OTHER
Cureety
INDUSTRY
Pharmaspecific
UNKNOWN
ProPens
UNKNOWN
Centre Hospitalier de Bligny
OTHER